Integrating measures of remnant cholesterol and inflammation: risky business?

Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol 2013; 61: 427-36.

Google Scholar

TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute; Crosby J, Peloso GM, Auer PL, et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med 2014; 371: 22-31.

Google Scholar

Dewey FE, Gusarova V, Dunbar RL, et al. Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N Engl J Med 2017; 377: 211-21.

Google Scholar

Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 2023; 148: 1606-35.

Google Scholar

Minhas AMK, Mathew RO, Sperling LS, et al. Prevalence of the cardiovascular-kidney-metabolic syndrome in the United States. J Am Coll Cardiol 2024; 83: 1824-6.

Google Scholar

Ridker PM. How common is residual inflammatory risk? Circ Res 2017; 120: 617-9.

Google Scholar

Wang L, Li H, Wang L, et al. Remnant cholesterol inflammatory index and mortality in cardiovascular-kidney-metabolic syndrome: a national study. Arch Med Sci 2026; 22: 672-83.

Google Scholar

Khan SS, Matsushita K, Sang Y, et al. Development and validation of the American Heart Association’s PREVENT equations. Circulation 2024; 149: 430-49.

Google Scholar

10.

Ramjee V, Sperling LS, Jacobson TA. Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math. J Am Coll Cardiol 2011; 58: 457-63.

Google Scholar

11.

Sperling LS, Mechanick JI, Neeland IJ, et al. The CardioMetabolic Health Alliance: working toward a new care model for the metabolic syndrome. J Am Coll Cardiol 2015; 66: 1050-67.

Google Scholar

12.

Sperling L, Irazola V, Partarrieu J, et al. WHF Roadmap for integrated care in people living with – or at risk of – cardiovascular disease and multiple long-term conditions. Glob Heart 2026; 21: 28.

Google Scholar

Submit your paper

eISSN:	1896-9151
ISSN:	1734-1922